Alzamend Neuro ALZN
NASDAQ ALZN
$1.12 -0.13 (-10.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Debt Ratio (2024)

Updated

Alzamend Neuro's (ALZN) Debt Ratio stood at 0.48 in fiscal Q4 2024 (quarter ended Apr 30, 2024).

Analysis

Alzamend Neuro (ALZN) Debt Ratio (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Alzamend Neuro 5.31 Mn -10.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2024 0.48
API Access

Alzamend Neuro Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ALZN&period=max&api_key=YOUR_API_KEY